OriGem Biotech participated in Bio International Covention 2022, an international biotechnology fair, for the first time as a Taiwanese startup biotech company, introducing its own smart single-cell capture and culture platform called CellGem. CellGem is a user-friendly platform designed for single-cell capture and culture purposes. During the exhibition, two American distributors approached OriGem to inquire about their technology and requested samples. With the assistance of TAITRA, the samples were sent to these two agents in San Diego, and contracts with the distributors were successfully signed earlier this year.